Advanced Biomed Inc. Common Stock (ADVB) vs Curanex Pharmaceuticals Inc Common Stock (CURX)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and Curanex Pharmaceuticals Inc Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.34HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CURX
Curanex Pharmaceuticals Inc Common Stock
$4.96HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ADVB vs CURX
growth of $100 · dividends reinvested · last 1yADVB -28.4% (-28.4%/yr)CURX -93.8% (-93.8%/yr)ADVB compounded faster over this window
Log scale — wide-divergence pair
ADVB CURX
ADVB vs CURX: by the numbers
- •ADVB is the larger company ($9M vs $7M market cap).
Metrics side by side
Valuation
| Metric | ADVB | CURX |
|---|---|---|
| P/B ratio | 0.95 | 1.47 |
Profitability
| Metric | ADVB | CURX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -7.36% | -218.65% |
| ROIC | -11.06% | -208.39% |
Go deeper
Dig into the metrics
Advanced Biomed Inc. Common Stock ROECuranex Pharmaceuticals Inc Common Stock ROEAdvanced Biomed Inc. Common Stock operating marginCuranex Pharmaceuticals Inc Common Stock operating marginAdvanced Biomed Inc. Common Stock revenue growthCuranex Pharmaceuticals Inc Common Stock revenue growthAdvanced Biomed Inc. Common Stock free cash flowCuranex Pharmaceuticals Inc Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.